Huller Kelly 4

What Happened

• Kelly Huller, EVP, General Counsel & Corporate Secretary of Globus Medical (GMED), exercised stock options and sold shares on 2026-02-25.
• The filing reports an exercise/conversion of options for 20,000 shares at $43.58/share (total cost $871,600) and an open-market sale of 20,000 shares at $94.50/share (total proceeds $1,890,000).
• The filing also shows a related disposition of 20,000 shares at $0.00 (reported as a derivative disposition). The open-market sale was executed under a Rule 10b5-1 trading plan and is therefore likely pre-planned rather than a discretionary trade.

Key Details

• Transaction date: 2026-02-25; Form 4 filed: 2026-02-27 (appears timely).
• Exercise: 20,000 shares @ $43.58 = $871,600 (transaction code M).
• Sale: 20,000 shares @ $94.50 = $1,890,000 (transaction code S); footnote: sale pursuant to Rule 10b5-1 plan dated Nov 12, 2025.
• Additional reported disposition: 20,000 shares @ $0.00 (transaction code M / derivative); options were granted Jan 22, 2019 and are fully vested.
• Shares owned after the transactions: not specified in the provided filing details.

Context

• This appears to be an exercise-and-sell pattern: options were exercised and shares were sold the same day, which is commonly done to capture option value and cover exercise/tax costs; the $0.00 disposition line in the filing often reflects share surrender or withholding for taxes/exercise but the filing does not explicitly state the reason.
• The open-market sale was executed under a pre-established 10b5-1 plan (per footnote), which typically indicates the sale was scheduled in advance and not a timing judgment by the insider.